Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,474
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
for
Hormone-receptor-positive Breast Cancer,
Location: Seattle WA, Iowa City IA, Houston TX
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06756932
Phase 1, Recruiting
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Seattle WA, Portland OR, Palo Alto CA, Duarte CA,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 18 - 66
Code: NCT06859424
Phase 2, Recruiting
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
for
Financial Hardship, Alzheimer's Disease (AD),
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT06922188
Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Location: Seattle WA, Portland OR, Duarte CA, Dallas TX,
Sponsor: Eureka Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04864054
Phase 1, Phase 2, Recruiting
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
for
Advanced Hepatocellular Carcinoma
Location: Seattle WA, Duarte CA, Dallas TX, Chicago IL,
Sponsor: Iterion Therapeutics
Sex: All
Age: 18+
Code: NCT05797805
Phase 1, Phase 2, Recruiting
Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
for
Non-Malignant Neoplasm
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18 - 49
Code: NCT04083183
Phase 1, Phase 2, Recruiting
Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
for
Cytokine Release Syndrome
Location: Seattle WA, Orange CA, Pittsburgh PA, Augusta GA,
Sponsor: CytoAgents, Inc.
Sex: All
Age: 18+
Code: NCT05905328
Phase 1, Phase 2, Recruiting
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
for
Carcinoma, Non-Small-Cell Lung
Location: Seattle WA, Portland OR, Milwaukee WI, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06855771
Phase 2, Recruiting
TGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients